Grant: Project Grant
University of Toronto
$691,180.00
Targeting brain inflammation and its resolution. Omega-3 fatty acids, omega-6 fatty acids or both?
EF 2016-17
Résumé
Neurodegenerative diseases are a relatively broad class of neurological disorders, however, recent evidence suggests that dietary n-3 polyunsaturated fatty acids (PUFA), commonly
found in fish, may be of benefit in preventing or treating these diseases, including Alzheimer's Disease. One common link between neurodegenerative disorders is that they have a neuroinflammatory component. It is well established that n-3 PUFA are anti-inflammatory in the periphery, but whether or not they are also anti-inflammatory within the brain is unknown. It is thought that one way omega-3 might be beneficial in the brain is by interfering with omega-6 fatty acid metabolism. We have developed diets that can lower or increase omega-6s. By combining these approaches we will be able figure out if it is the omega-3s, the omega-6s or both. This is very important as, currently, diets are very high in omega-6 fatty acids and, thus, there is a lot of room to decrease them. The objective of the current proposal is to test if n-3 PUFA are anti-inflammatory within the mouse brain and to evaluate the mechanisms by which they accomplish this. We have established a mouse model of neuroinflammation to test this hypothesis and our preliminary results strongly suggest that docosahexaenoic acid (DHA) is protective against neuroinflammation. Having a better understanding whether increasing omega-3 fatty acids and or decreasing omega-6 fatty acids can protect us from the neuroinflammation associated with Alzheimer's disease could lead to new therapies for prevention.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
356320
Name
Bazinet Richard P
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Targeting brain inflammation and its resolution. Omega-3 fatty acids, omega-6 fatty acids or both?
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$691,180
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Nutrition; Nutrition And Brain; Nutrition And Fatty Acid Metabolism; Nutrition And Inflammation; Omega-3 Fatty Acids
Abstract
Neurodegenerative diseases are a relatively broad class of neurological disorders, however, recent evidence suggests that dietary n-3 polyunsaturated fatty acids (PUFA), commonly
found in fish, may be of benefit in preventing or treating these diseases, including Alzheimer's Disease. One common link between neurodegenerative disorders is that they have a neuroinflammatory component. It is well established that n-3 PUFA are anti-inflammatory in the periphery, but whether or not they are also anti-inflammatory within the brain is unknown. It is thought that one way omega-3 might be beneficial in the brain is by interfering with omega-6 fatty acid metabolism. We have developed diets that can lower or increase omega-6s. By combining these approaches we will be able figure out if it is the omega-3s, the omega-6s or both. This is very important as, currently, diets are very high in omega-6 fatty acids and, thus, there is a lot of room to decrease them. The objective of the current proposal is to test if n-3 PUFA are anti-inflammatory within the mouse brain and to evaluate the mechanisms by which they accomplish this. We have established a mouse model of neuroinflammation to test this hypothesis and our preliminary results strongly suggest that docosahexaenoic acid (DHA) is protective against neuroinflammation. Having a better understanding whether increasing omega-3 fatty acids and or decreasing omega-6 fatty acids can protect us from the neuroinflammation associated with Alzheimer's disease could lead to new therapies for prevention.
Competitiondate
201610
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Bazinet, Richard P
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $691,180~ $0~